Vofopitant Completed Phase 2 Trials for Post Traumatic Stress Disorder (PTSD) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00383786 | Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder |